Cargando…

Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction

BACKGROUND AND OBJECTIVES: High dose rosuvastatin loading before percutaneous coronary interventions (PCI) reduces the myocardial damage and the incidence of adverse cardiac events in patients with stable angina and acute coronary syndrome. However, no studies are present yet about rosuvastatin load...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Won, Yun, Kyeong Ho, Kim, Eun Kyoung, Kim, Yong Cheol, Joe, Dai-Yeol, Ko, Jum Suk, Rhee, Sang Jae, Lee, Eun Mi, Yoo, Nam Jin, Kim, Nam-Ho, Oh, Seok Kyu, Jeong, Jin-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958612/ https://www.ncbi.nlm.nih.gov/pubmed/24653736 http://dx.doi.org/10.4070/kcj.2014.44.2.76

Ejemplares similares

Erratum to: Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction
por: Kim, Ji Won, et al.
Publicado: (2014)

Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy
por: Yun, Kyeong Ho, et al.
Publicado: (2014)

Left Ventricular Thrombus Associated with Takotsubo Cardiomyopathy: A Cardioembolic Cause of Cerebral Infarction
por: Shin, Seoung-Nam, et al.
Publicado: (2011)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Clinical Significance of On-Treatment Triglyceride Level in Patients Treated by Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome
por: Yun, Kyeong Ho, et al.
Publicado: (2009)

Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year
por: Yun, Kyeong Ho, et al.
Publicado: (2013)

Antioxidative Activity after Rosuvastatin Treatment in Patients with Stable Ischemic Heart Disease and Decreased High Density Lipoprotein Cholesterol
por: Park, Do-Sim, et al.
Publicado: (2016)

Protective Effect of Cilostazol Against Restraint Stress Induced Heart Failure in Post-Myocardial Infarction Rat Model
por: Lee, Moon Young, et al.
Publicado: (2020)

The Number of Endothelial Progenitor Cells is Decreased in Patients With Non-Dipper Hypertension
por: Kim, Seunghwan, et al.
Publicado: (2012)

Effect of Previous Statin Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2011)

Usefulness of Myocardial Longitudinal Strain in Prediction of Heart Failure in Patients with Successfully Reperfused Anterior Wall ST-segment Elevation Myocardial Infarction
por: Lee, Sun Hwa, et al.
Publicado: (2019)

Comparison of Long‐Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct‐Related Artery–Only Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction With Cardiogenic Shock
por: Lee, Joo Myung, et al.
Publicado: (2019)

Impact of Previous Angina on Clinical Outcomes in ST-Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention
por: Han, Xiongyi, et al.
Publicado: (2020)

The Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome
por: Jung, Lae-Young, et al.
Publicado: (2016)

Morphine Does Not Affect Myocardial Salvage in ST-Segment Elevation Myocardial Infarction
por: Gwag, Hye Bin, et al.
Publicado: (2017)

Predictors of decreased left ventricular function subsequent to follow-up echocardiography after percutaneous coronary intervention following acute ST-elevation myocardial infarction
por: Kim, Dong-Hee, et al.
Publicado: (2018)

Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction
por: Hong, David, et al.
Publicado: (2019)

Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
por: Adel, Esraa M., et al.
Publicado: (2022)

Acute Stent Thrombosis and Heparin Induced Thrombocytopenia in a Patient With ST-Segment Elevation Myocardial Infarction
por: Shin, Hong Won, et al.
Publicado: (2012)

Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction
por: Shon, Ho Sun, et al.
Publicado: (2017)

Effects of High-dose Atorvastatin Pretreatment in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Study
por: Kim, Eun Kyoung, et al.
Publicado: (2015)

Prognostic Implications of Door‐to‐Balloon Time and Onset‐to‐Door Time on Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Park, Jonghanne, et al.
Publicado: (2019)

Suboptimal medical care of patients with ST-Elevation Myocardial Infarction and Renal Insufficiency: results from the Korea acute Myocardial Infarction Registry
por: Choi, Joon Seok, et al.
Publicado: (2012)

Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction
por: Park, Hun-Jun, et al.
Publicado: (2015)

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
por: Lee, Jiwoo, et al.
Publicado: (2020)

Impact of Acute Kidney Injury on Clinical Outcomes after ST Elevation Acute Myocardial Infarction
por: Kim, Min Jee, et al.
Publicado: (2011)

Prognostic Value of Left Atrium Remodeling after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Acute Myocardial Infarction
por: Cho, Jang Hyun, et al.
Publicado: (2012)

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
por: Kim, Kyung‐Jin, et al.
Publicado: (2016)

Feasibility of primary percutaneous coronary intervention via the distal radial approach in patients with ST-elevation myocardial infarction
por: Kim, Yongcheol, et al.
Publicado: (2021)

Differential Clinical Implications of High-Degree Atrioventricular Block Complicating ST-Segment Elevation Myocardial Infarction according to the Location of Infarction in the Era of Primary Percutaneous Coronary Intervention
por: Kim, Kyung Hwan, et al.
Publicado: (2016)

Can documented coronary vasospasm be the smoking gun in settling the etiology of sudden cardiac death?
por: Kim, Nam-Ho, et al.
Publicado: (2017)

Introduction of Wearable Device in Cardiovascular Field for Monitoring Arrhythmia
por: Kim, Nam Ho, et al.
Publicado: (2021)

Gender Differences in Factors Related to Prehospital Delay in Patients with ST-Segment Elevation Myocardial Infarction
por: Kim, Hee-Sook, et al.
Publicado: (2017)

Coronary Stents in Patients with ST-Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention
por: Ahmed, Khurshid, et al.
Publicado: (2012)

Percutaneous Coronary Intervention for Acute Myocardial Infarction in Elderly Patients with Renal Dysfunction: Results from the Korea Acute Myocardial Infarction Registry
por: Lim, Sang Yup, et al.
Publicado: (2013)

Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Serial Plasma Levels of Angiogenic Factors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Kim, Bo Hyun, et al.
Publicado: (2012)

Comparative clinical implications of admission electrocardiographic findings for patients with non-ST-segment elevation myocardial infarction
por: Jin, Eun-Sun, et al.
Publicado: (2016)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
por: Zhou, Langping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gfdkatp2vo4sjadnqb7e45e23v